-
www.ahrq.gov/sites/default/files/wysiwyg/priority-populations/aging-well-strategic-plan.pdf
August 01, 2024 - quality of health services, medical practice patterns, access to healthcare programs and outcomes of treatments … Evidence Map on Home and Community Based
Services, and a Systematic Review Update on Nonsurgical Treatments … among women in primary
care by implementing evidence into primary care practices for nonsurgical treatment … AHRQ, in partnership with the National Institute of Diabetes and Digestive and Kidney
Diseases, is developing … Research encouraged applicants to build upon AHRQ’s work in partnership with the National Institute of Diabetes
-
psnet.ahrq.gov/web-mm/always-check-muscle-twitch-residual-neuromuscular-block-after-removal-gastric-balloon
January 29, 2021 - patient in this case presumably received an intragastric balloon as a temporary and minimally invasive therapy … Lancet Diabetes Endocrinol . 2019;7(3):231-240. [ Free full text ] Nianogo RA, Arah OA. … Forecasting obesity and type 2 diabetes incidence and burden: the ViLA-Obesity Simulation Model. … The role of a deep neuromuscular block in the treatment of mandibular subcondylar fractures. … Onset and duration of action of rocuronium in children receiving chronic anticonvulsant therapy.
-
psnet.ahrq.gov/sites/default/files/2022-01/final_spotlight_stacked_opioid_administration_01.03.2022.pdf
January 01, 2022 - medical history of morbid obesity,
hypertension, heart failure, chronic kidney disease (stage 3),
diabetes … drug class, opioids are associated with wide interindividual variability
in response and a narrow therapeutic … – Treatment modalities that incorporate non-pharmacologic therapy, ice/heat,
elevation, and physical … A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring … therapy to
meet patient needs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
April 01, 2021 - Evidence does not
indicate an optimal treatment
regimen or duration of
therapy, or identify whether … as usual,
waitlists, no treatment, or
other active treatments, in
adults with posttraumatic
stress … Improving diabetes-
related health care
utilization?
c. … Use of
Cardiac Resynchronization Therapy. … Behavioral Programs for Type 1 Diabetes
Mellitus: A Systematic Review and Meta-
analysis.
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … Helminthic therapy (pig whipworm) for treatment-resistant ulcerative colitis No high-impact potential … Finally, one
expert representing a clinical perspective stated that no therapies are available to promote … Bethesda (MD): National Institute of
Diabetes and Digestive and Kidney Diseases
(NIDDK), National
-
psnet.ahrq.gov/node/33574/psn-pdf
March 15, 2025 - importance of including the patient as a partner and ensuring that
patients understand their illnesses and treatments … For example, a patient with diabetes must measure her own blood sugars and perhaps adjust
https://psnet.ahrq.gov
-
hcup-us.ahrq.gov/reports/statbriefs/sb20.pdf
December 01, 2006 - obesity are serious; the condition is linked to
increased risk of hypertension, high blood cholesterol, diabetes … Clinical Guidelines on the Identification,
Evaluation, and Treatment of Overweight and Obesity in Adults … Biliary
tract disease, diabetes, and abdominal hernia were also top 20 principal conditions for obese … COPD) 35,000 2.2 1.9*
14 Schizophrenia 33,700 2.2 1.1*
15 Rehabilitation care 33,500 2.1 1.6*
16 Diabetes
-
hcup-us.ahrq.gov/reports/statbriefs/sb20.jsp
December 20, 2006 - obesity are serious; the condition is linked to increased risk of hypertension, high blood cholesterol, diabetes … Biliary tract disease, diabetes, and abdominal hernia were also top 20 principal conditions for obese … Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults … Schizophrenia
33,700
2.2
1.1*
15
Rehabilitation care
33,500
2.1
1.6*
16
Diabetes
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/improve/coordination/ccqmpc/cati-script.pdf
July 01, 2016 - or other primary care
professionals in this office know about your past health problems or past treatments … healthcare (e.g., flu shot), medicine, surgery, or other treatment. … Professional treatment refers to any
treatment supervised by a health professional.
1 YES, I have … received professional treatment for this condition
2 NO, I have NOT received professional treatment … Diabetes?
66k. Osteoporosis?
66l. Skin cancer?
66m. Any other kind of cancer?
66n.
-
digital.ahrq.gov/sites/default/files/docs/phr-impact-chronic-disease-slides-012512.pdf
January 25, 2012 - ”
■ “I used it with the blood pressure and with my
diabetes so when I put my information in, I
could … adults; 30–40% older adults
Introduction to CPAP
■ CPAP = continuous
positive airway
pressure therapy … Consists of flow
generator, hose,
and mask
■ Prescribed for use
whenever asleep
■ Gold-standard
therapy … 2004; Flemons et al., 2004
CPAP Adherence Rates
■ Continuous positive airway pressure (CPAP)
therapy … group education
■ Clinical support
– Provision of additional telephone/clinic visits
with focus on therapeutic
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017189-trivedi-final-report-2010.pdf
January 01, 2010 - Scope: Despite the availability of new and effective treatments for MDD evidence continues to
demonstrate … For example, unlike chronic medical disorders like hypertension, diabetes
mellitus and asthma, use of … The CDSS will also alert the physician
if medication blood levels are not in the therapeutic range. … This includes medication choices for primary medications and
augmenting medications, as well as treatments … visit and the number of treatments visits.
-
psnet.ahrq.gov/node/49852/psn-pdf
February 01, 2019 - The Case
A 63-year-old man with a history of hypertension, coronary artery disease, and diabetes was … Existing legislation, known as the Emergency Medical Treatment and Labor Act (EMTALA), dictates that … with necessary therapy for severely ill patients awaiting transfer. … the physician requested transfer of the patient for
dermatologic and critical care evaluation and treatment … Emergency Medical Treatment & Labor Act (EMTALA). Center for Medicare and Medicaid Services.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/B73a4kJhxeaYyXK6gozbbY
May 24, 2022 - outcomes
Reporting bias not detected
Moderate for
benefit
VEGF inhibitors are considered first-line therapy … detected
Moderate for
no harm
VEGF inhibitors vs sham:
VEGF inhibitors are considered first-line therapy … Morphology and visual acuity in aflibercept and
ranibizumab therapy for neovascular age-related
macular … Oral zinc-therapy in age-related macular
degeneration: a double blind study. … Introducing
anti-vascular endothelial growth factor therapies
for AMD did not raise risk of myocardial
-
psnet.ahrq.gov/node/33816/psn-pdf
October 01, 2016 - characterize everyone who's eligible for care, those who have received specific diagnoses,
tests, and treatment … For
instance, major responsibility for following up women with gestational diabetes who have not had … We already mentioned
finding women who require postpartum assessment of diabetes status. … to identify patients who are at risk for problems
with opioid dependence or complications of opioid therapy
-
psnet.ahrq.gov/perspective/patient-safety-and-opioid-medications
January 01, 2015 - medications and muscle relaxants at "trigger points," nitrous oxide ("laughing gas"), as well alternative therapies … care, the way the use of ketorolac (Toradol), a nonopioid anti-inflammatory, has become first-line treatment … safe medication use research ( PA-16-421 ) and an initiative that will implement medication-assisted treatment … For acute pain, CDC recommends limiting duration of therapy, generally to one week or less. … interactive, telephone-based self-management support program to identify adverse events among ambulatory diabetes
-
www.ahrq.gov/patient-safety/quality-resources/tools/chtoolbx/measures/measure-9.html
August 01, 2025 - Outcomes Survey (ECHO™): The ECHO™ survey collects consumers' assessments about their behavioral health treatment … Care and Health Outcomes Survey (ECHO™) collects consumers' assessments about their behavioral health treatment … The ECHO™ survey assesses several aspects of care, including: Getting treatment and counseling quickly … Information about self-help groups and treatment options. Cultural competency of providers of care. … Treatment effectiveness. Health plan administrative and office staff services.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
August 01, 2014 - It may not be ethical to randomize or withhold
therapy based on troponin values alone, as ACS treatment … Therapeutic options
and likelihood of impact on outcomes may vary across
stages of CKD. … Many patients may already have
indications for these therapies; what additional treatment
should clinicians … next steps regarding how best to manage these patients
with elevated troponin levels (how and if treatments … would
vary from those treatments indicated by clinical factors
alone), the applicability of this screening
-
psnet.ahrq.gov/innovation/adverse-drug-event-ade-surveillance-and-pharmacist-counseling
June 28, 2023 - of the selected target medications used to treat four common primary care conditions: hypertension, diabetes … innovation team identified eligible patients with a newly prescribed medication to treat hypertension, diabetes … Healthcare Research and Quality (AHRQ), Health Information Technology, Center for Education and Research of Therapeutics … impact of pharmacological/pharmaceutical care on medication safety and patient-reported outcomes during treatment
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017855-friedman-final-report-2013.pdf
January 01, 2013 - For example, Lee et
al.2 found that dyads of chronic conditions in a VA population of diabetes mellitus … The most common diagnoses among study participants were hypertension
(51%), diabetes (34%), and asthma … Follow-up was also lower among patients with diabetes
(47%) than among non-diabetic patients (61%). … Follow-up was also lower
among patients with diabetes (47%) than among non-diabetic patients (61%). … Furthermore, participants tended to be fairly involved in their treatment management process.
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Implementation Guide
Statin Therapy for the Prevention and Treatment … Implementation Guide: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease (CVD) … Statin Therapy for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality … Figure 1: Artifact Relationship Diagram
Testing
The Statin Therapy for the Prevention and Treatment … CQL Q&As on the eCQI Resource Center
Statin Therapy for the Prevention and Treatment of Cardiovascular